In a @-month , single-centre open-label prospective trial , @ de novo live-donor kidney transplant recipients at low-immunological risk were randomised to a low-dose cyclosporine group which received a low dose of cyclosporine , short-term intensified EC-MPS dosing ( @mg/day to week @ , @mg/day thereafter ) and corticosteroids or a standard-dose cyclosporine group which received a standard dose of cyclosporine , standard EC-MPS dosing ( @mg/day ) and corticosteroids .